Clinical predictors of asthmatics in identifying subgroup requiring long-term tiotropium add-on therapy: a real-world study

BACKGROUND: According to several phase III studies, tiotropium [a long-acting muscarinic antagonist (LAMA)] is a well-tolerated add-on therapy to inhaled corticosteroids (ICS) for asthmatics with or without the addition of long-acting beta2-agonists (LABAs). However, real-world studies based on clin...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Thorac Dis
Auteurs principaux: Cheng, Wen-Chien, Liao, Wei-Chih, Wu, Biing-Ru, Chen, Chih-Yu, Shen, Meng-Fang, Chen, Wei-Chun, Hsia, Te-Chun, Tu, Chih-Yen, Chen, Chia-Hung, Hsu, Wu-Huei
Format: Artigo
Langue:Inglês
Publié: AME Publishing Company 2019
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6790467/
https://ncbi.nlm.nih.gov/pubmed/31656651
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2019.09.22
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires